The reported statements, read against the company's own industry.
Financials view
Market Capitalization
21.56BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Trailing P/E
10.59x
vs Medical Care Facilities peers
Updated Aug 28, 2026
Revenue (TTM)
21.81BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Profit Margin
10.27%
vs Medical Care Facilities peers
Updated Aug 28, 2026
Beta
1.23x
vs all stocks
Updated Aug 28, 2026
52-Week Change
44.37%
vs all stocks
Updated Aug 28, 2026
Market Capitalization
21.56BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Enterprise Value
36.68BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Trailing P/E
10.59x
vs Medical Care Facilities peers
Updated Aug 28, 2026
Forward P/E
12.85x
vs Medical Care Facilities peers
Updated Aug 28, 2026
PEG Ratio
0.0497x
vs Medical Care Facilities peers
Updated Aug 28, 2026
Price to Sales (TTM)
0.9884x
vs Medical Care Facilities peers
Updated Aug 28, 2026
Price to Book (MRQ)
4.63x
vs Medical Care Facilities peers
Updated Aug 28, 2026
Enterprise to Revenue
1.68x
vs Medical Care Facilities peers
Updated Aug 28, 2026
Enterprise to EBITDA
7.57x
vs Medical Care Facilities peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 6.41×.Updated Aug 28, 2026
Gross Margin
83.71%
vs Medical Care Facilities peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 41.66%.Updated Aug 28, 2026
Profit Margin
10.27%
vs Medical Care Facilities peers
Updated Aug 28, 2026
Operating Margin
18.16%
vs Medical Care Facilities peers
Updated Aug 28, 2026
Return on Assets (TTM)
8.32%
vs Medical Care Facilities peers
Updated Aug 28, 2026
Return on Equity (TTM)
37.34%
vs Medical Care Facilities peers
Updated Aug 28, 2026
Revenue (TTM)
21.81BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Revenue per Share (TTM)
252.49USDUpdated Aug 28, 2026
Quarterly Revenue Growth
6.80%
vs Medical Care Facilities peers
Updated Aug 28, 2026
Gross Profit (TTM)
9.09BUSD
vs all stocks (USD)
Updated Aug 28, 2026
EBITDA (TTM)
5.72BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Net Income (TTM)
2.24BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Quarterly Earnings Growth (YoY)
186.80%
vs Medical Care Facilities peers
Updated Aug 28, 2026
Operating Cash Flow (TTM)
4.02BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Levered Free Cash Flow (TTM)
2.25BUSD
vs all stocks (USD)
Updated Aug 28, 2026
5-Year Average Dividend Yield
2.75%
vs all stocks
Updated Aug 28, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Aug 28, 2026
Minority Interest (Equity)
4.75BUSDFY2025 · Dec 31, 2025
Revenue
21.31BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
3.78BUSDFY2025 · Dec 31, 2025
Gross Profit
17.53BUSDFY2025 · Dec 31, 2025
Operating Income
3.44BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
2.80BUSDFY2025 · Dec 31, 2025
Income Tax Expense
433.00MUSDFY2025 · Dec 31, 2025
Net Income
1.41BUSDFY2025 · Dec 31, 2025
EBIT
3.62BUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
4.68BUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
8.71BUSDFY2025 · Dec 31, 2025
Other Operating Expenses
4.52BUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
821.00MUSDFY2025 · Dec 31, 2025
EPS (Basic)
15.61USDFY2025 · Dec 31, 2025
EPS (Diluted)
15.49USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
90.15MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
90.15MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
2.37BUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
-960.00MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
3.51BUSDFY2025 · Dec 31, 2025
Free Cash Flow
2.54BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
2.88BUSDFY2025 · Dec 31, 2025
Income Tax Paid
450.00MUSDFY2025 · Dec 31, 2025
Interest Paid
865.00MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
2.37BUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
863.00MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
9.00MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
104.00MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
29.00MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
20.00MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
209.00MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-89.00MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-972.00MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-308.00MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-90.00MUSDFY2025 · Dec 31, 2025
Sale of Investments
93.00MUSDFY2025 · Dec 31, 2025
Other Investing Activity
2.00MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-1.27BUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
2.28BUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-2.37BUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-1.39BUSDFY2025 · Dec 31, 2025
Other Financing Charges
-919.00MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-2.40BUSDFY2025 · Dec 31, 2025
Shares Outstanding
80.51MSharesUpdated Aug 28, 2026
Float Shares
79.54MSharesUpdated Aug 28, 2026
Shares Short
2.52MSharesUpdated Aug 28, 2026
Short Ratio
1.90days
vs all stocks
Updated Aug 28, 2026
Short % of Shares Outstanding
3.68%
vs all stocks
Updated Aug 28, 2026
% Held by Insiders
1.00%
vs all stocks
Updated Aug 28, 2026
% Held by Institutions
102.42%
vs all stocks
Updated Aug 28, 2026
Total Cash (MRQ)
2.17BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Total Cash per Share (MRQ)
26.95USDUpdated Aug 28, 2026
Total Debt (MRQ)
13.25BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Total Debt to Equity (MRQ)
1.52x
vs Medical Care Facilities peers
Updated Aug 28, 2026
Current Ratio (MRQ)
1.41x
vs Medical Care Facilities peers
Updated Aug 28, 2026
Book Value per Share (MRQ)
57.86USDUpdated Aug 28, 2026
Total Assets
29.68BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
7.85BUSDFY2025 · Dec 31, 2025
Total Liabilities
20.70BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
21.83BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
16.24BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
4.46BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
2.88BUSDFY2025 · Dec 31, 2025
Accounts Receivable
2.56BUSDFY2025 · Dec 31, 2025
Inventory
348.00MUSDFY2025 · Dec 31, 2025
Accounts Payable
1.36BUSDFY2025 · Dec 31, 2025
Short-term Debt
79.00MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
1.81BUSDFY2025 · Dec 31, 2025
Long-term Debt
13.09BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.71BUSDFY2025 · Dec 31, 2025
Common Stock (Book)
8.00MUSDFY2025 · Dec 31, 2025
Retained Earnings
4.42BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
8.97BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
157.58USDUpdated Aug 28, 2026
52-Week High
283.05USDUpdated Aug 28, 2026
52-Week Change
44.37%
vs all stocks
Updated Aug 28, 2026
Beta
1.23x
vs all stocks
Updated Aug 28, 2026
50-Day MA
227.53USDUpdated Aug 28, 2026
200-Day MA
206.19USDUpdated Aug 28, 2026
Avg 10-Day Volume
739.25KSharesUpdated Aug 28, 2026
Avg 30-Day Volume
1.10MSharesUpdated Aug 28, 2026
Diluted EPS (TTM)
25.28USDUpdated Aug 28, 2026
Other Income / Expense
182.00MUSDFY2025 · Dec 31, 2025
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.09: grey zoneSignificant
Altman Z-Score: 2.09
High earnings qualityNotable
Earnings Quality Score: 0.52
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $21.81B, higher than 95% of all stocks globallySignificant